Albemarle CorporationALBEarnings & Financial Report
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...
ALB Q1 FY2026 Key Financial Metrics
Revenue
$1.4B
Gross Profit
$501.0M
Operating Profit
$233.5M
Net Profit
$319.1M
Gross Margin
35.1%
Operating Margin
16.3%
Net Margin
22.3%
YoY Growth
32.7%
EPS
$2.34
Albemarle Corporation Q1 FY2026 Financial Summary
Albemarle Corporation reported revenue of $1.4B (up 32.7% YoY) for Q1 FY2026, with a net profit of $319.1M (up 671.7% YoY) (22.3% margin). Cost of goods sold was $927.8M, operating expenses totaled $267.5M.
Key Financial Metrics
| Total Revenue | $1.4B |
|---|---|
| Net Profit | $319.1M |
| Gross Margin | 35.1% |
| Operating Margin | 16.3% |
| Report Period | Q1 FY2026 |
Albemarle Corporation Annual Revenue by Year
Albemarle Corporation annual revenue history includes year-by-year totals (for example, 2025 revenue was $5.1B).
| Year | Annual Revenue | |
|---|---|---|
| 2025 | $5.1B | — |
| 2024 | $5.4B | — |
| 2023 | $9.6B | — |
| 2022 | $7.3B | — |
Albemarle Corporation Quarterly Revenue & Net Profit History
Albemarle Corporation results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $1.4B | +32.7% | $319.1M | 22.3% |
| Q4 FY2025 | $1.4B | +15.9% | $-414.2M | -29.0% |
| Q3 FY2025 | $1.3B | -3.5% | $-160.7M | -12.3% |
| Q2 FY2025 | $1.3B | -7.0% | $22.9M | 1.7% |
| Q1 FY2025 | $1.1B | -20.9% | $41.3M | 3.8% |
| Q4 FY2024 | $1.2B | -47.7% | $75.3M | 6.1% |
| Q3 FY2024 | $1.4B | -41.4% | $-1.1B | -78.9% |
| Q2 FY2024 | $1.4B | -39.7% | $-188.2M | -13.2% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.43B | $1.35B | $1.23B | $1.08B | $1.33B | $1.31B | $1.43B | $1.43B |
| YoY Growth | -39.7% | -41.4% | -47.7% | -20.9% | -7.0% | -3.5% | 15.9% | 32.7% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $18.39B | $17.46B | $16.61B | $17.00B | $17.29B | $17.15B | $16.37B | $15.14B |
| Liabilities | $7.17B | $7.21B | $6.65B | $6.97B | $7.05B | $7.15B | $6.84B | $5.03B |
| Equity | $11.22B | $10.24B | $9.96B | $10.03B | $10.24B | $10.00B | $9.53B | $10.11B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $362.9M | $240.5M | $674000 | $545.4M | $-7.2M | $355.6M | $388.5M | $346.2M |